The familial aggregation rate is lower in East Asia but higher in West and South Asia; the genetic susceptibility to IBD in Asian population is different from that in Western countries, where it is not associated with NOD2/CARD15 mutations [25]. Here, NOD2 is linked to inflammatory bowel disease.